Sight Sciences (NASDAQ: SGHT) only recently made its public debut. Since the company's initial public offering last summer, shares have plunged by nearly 50%. Now, it's not uncommon for newly public companies to see shares plunge, even after a strong entrance to the market. Is this company, which markets medical devices to treat diseases of the eye, one that investors should put on their watch list right now? In this segment of Backstage Pass , recorded on Dec. 13 , Fool contributors Asit Sharma, Jason Hall, and Rachel Warren discuss.
For further details see:
Should Investors Consider Sight Sciences Stock?